PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,243,697 | compar genom analysi mycobacteria focus trna non code rna mycobacterium genus encompass least name speci mani caus sever diseas tuberculosi non tuberculosi mycobacteria ntm also infect human anim emerg concern show high resist common use antibiot other use evalu bioremedi includ anticanc vaccin | D000604;D009161 | T007;T126;T116 |
36,243,696 | unintend medic discrep associ factor upon patient admiss intern medicin ward identifi medic reconcili medic reconcili medrec wide accept tool identif resolut unintend medic discrep umd | D059065;D010343 | T058 |
36,243,695 | use mix method identifi communic skill train prioriti chines general practition diabet care china diabet care gradual shift secondari primari care great infrastructur invest gp train howev gps china lack communic skill train huge obstacl communic patient primari care studi seek identifi train prioriti evid base appropri context primari care china meet real need gps peopl diabet | D003920;D058005 | T047;T097 |
36,243,694 | pan cancer analysi oncogen tnfaip identifi prognost valu immunolog function acut myeloid leukemia tumor necrosi factor alpha induc protein tnfaip tnf induc gene appear particip inflamm immun respons hematopoiesi carcinogenesi howev potenti role tnfaip develop acut myeloid leukemia aml remain unknow yet therefor aim studi biolog role tnfaip leukemogenesi | D015470;D014409 | T191;T116;T129 |
36,243,693 | evalu safeti efficaci novel anatom classif dual anchor theori optim tavr strategi pure sever aortic regurgit aurora prospect cohort studi success rate transcathet aortic valv replac tavr aortic regurgit ar patient relat low account absenc calcifi anchor structur morpholog classif correspond tavr strategi ar lack yet | D001022;D001024;D006350;D065467 | T061;T047;T074 |
36,243,692 | awar willing accept syphili chemoprophylaxi among men sex men three citi china cross section studi awar willing use doxycyclin base syphili chemoprophylaxi among men sex men msm china remain larg unknown | D015658;D000072339;D013587 | T098;T047 |
36,243,691 | assess ad valu context stress detect wearabl data insomnia eat disord heart problem even stroke ill reveal negat impact stress overload health well earli detect stress therefor utmost import wherea gold standard detect stress mean questionnair recent work use wearabl sensor find continu qualit physic marker stress physiolog stress respons eg increas heart rate sweat chill might also occur sport profound approach need stress detect pure consid physiolog data | D000076251 | T073 |
36,243,690 | frequenc cypd allel impact clinic outcom adjuv tamoxifen therapi syrian breast cancer patient tamoxifen one fundament pillar adjuv endocrin therapi hormon receptor posit breast cancer howev patient receiv tamoxifen experi tumor relaps cypd encod extrem polymorph cypd gene rate limit enzym tamoxifen bioactiv studi aim determin frequenc clinic relev cypd allel evalu impact respons tamoxifen cohort syrian breast cancer patient | D009369;D013629 | T191;T109;T121 |
36,243,689 | communiti pharmacist counsel practic patient experi topic corticosteroid onlin survey klang valley malaysia communiti pharmacist cps play import role patient counsel regard use topic corticosteroid tcs assess cp self report counsel practic regard tcs patient report counsel experi | D003879;D010595 | T121;T097 |
36,243,688 | new insight genet resist paratuberculosi holstein cattl via singl step genom evalu bovin paratuberculosi john diseas jd contagi incur diseas caus mycobacterium avium subsp paratuberculosi map advers effect anim welfar difficult control lead serious econom consequ import line defens diseas host genet resist map fulli understood could improv select breed use larg dataset holstein cow anim includ cow elisa serolog phenotyp anim genotyp appli singl step singl nucleotid polymorph snp best linear unbias predict approach investig genet determin under resist diseas herit estim identif relev genom region estim genet trend reliabl relat risk factor associ genom predict | D002418;D016927;D010283 | T007;T047 |
36,243,687 | structur expert elicit inform long term surviv extrapol use altern parametr distribut case studi car therapi relaps refractori multipl myeloma aim extend tradit parametr model use extrapol surviv cost effect analys cea integr individu level patient data ipd clinic trial estim expert regard long term surviv illustr use case studi evalu surviv patient tripl class expos relapsedrefractori multipl myeloma treat chimer antigen receptor car cell therapi idecabtagen vicleucel ide cel bb karmma phase singl arm trial | D009101;D000076962 | T191;T192;T116;T129 |
36,243,686 | gps meet accredit standard implement activ perceiv improv attribut general practic accredit healthcar accredit wide implement tool use enhanc qualiti care underpin qualiti control howev research spars accredit process general practic aim studi explor team base implement activ preced accredit associ self perceiv improv emerg prepared prepared urgent diseas cardiac arrest handl prescript renew danish general practic | D058006;D058005 | T091;T097 |
36,243,685 | gamma secretas inhibitor induc cytotox adult cell leukemia cell line despit notch express activ mutat notch driver cell type acut lymphoblast leukemialymphoma secretas inhibitor gsi suppress function notch expect molecular target agent notch also express malign neoplasm aim determin function notch express effect gsi adult cell leukemialymphoma atl caus long term human cell leukemia virus type htlv infect | D015368;D015459 | T191;T005 |
36,243,684 | perspect cancer screen particip high urban region q methodolog studi hagu netherland netherland host mani european countri three popul base cancer screen programm csps overal uptak among csps high decreas recent year especi high urban region uptak rate tend fall minim effect rate set world health organ understand reason under decis citizen partak cps essenti order optim current screen particip rate aim studi explor various perspect concern cancer screen among inhabit hagu high urban region netherland | D055088;D009369 | T191;T058;T060 |
36,243,683 | effect let microrna c c chemokin receptor type express cellular function prognosi esophag squamous cell carcinoma c c chemokin receptor type ccr particip chemotact metastat respons various cancer includ esophag squamous cell carcinoma escc microrna mirna let suppress migrat invas various type cancer cell downregul ccr express | D004938;D000077277;D035683 | T191;T123;T114 |
36,243,682 | percept provid use mental health gap action programm intervent guid mhgap ig electron version smartphon base clinic guidanc nigerian primari care set take advantag rapid increas access digit technolog low middl incom countri world health organ launch electron version mental health gap action programm intervent guid emhgap ig suitabl use smartphon tablet non specialist primari healthcar provid phcws deliv evid base intervent prioriti mental neurolog substanc use disord assess percept phcws feasibl accept benefit use smartphon base clinic guidanc emhgap ig manag peopl mental health condit nigeria method explor view phcws rural urban primari health clinic phcs south western nigeria carri use depth key inform qualit interview nurs n communiti health offic n communiti health extens worker n addit two focus group discuss compris eight particip drawn across rang characterist phcws also conduct themat analysi conduct use three stage constant comparison techniqu refin categoris data | D008603;D000068997 | T041;T073 |
36,243,681 | pikca mutat associ poor postop prognosi patient pulmonari pleomorph carcinoma retrospect cohort studi pulmonari pleomorph carcinoma ppc rare type non small cell lung cancer character high malign poor prognosi ppc associ high frequenc postop relaps show resist chemotherapi high malign cancer associ genom instabl relat mutat tumor suppressor gene tumor protein p tp ataxia telangiectasia mutat atm addit signal pathway involv oncogen phosphatidylinositol bisphosph kinas catalyt subunit alpha pikca epiderm growth factor receptor egfr associ resist chemotherapi howev associ ppc gene mutat remain unknown investig impact tp atm pikca egfr mutat postop prognosi ppc | D002277;D002289;D008175 | T191 |
36,243,680 | comprehens analysi penil cancer region highest worldwid incid reveal new insight diseas although penil cancer pc uncommon develop countri widespread develop countri state maranho northeast brazil highest global incid record pc despit socioeconom vulner attribut human papillomavirus hpv infect studi aim determin histopatholog featur preval hpv infect immunohistochem profil pc maranho | D030361;D010412 | T191;T047 |
36,243,679 | covid surveil flemish school system develop systemat data collect within public health school system descript analysi case report octob june age specif distribut sar cov case school well describ report statist reflect intens communiti transmiss shape bias age depend test regim well effect age specif intervent case surveil system introduc within flemish school health prevent network school year present epidemiolog data school report case pre primari secondari school identifi case surveil system conjunct test data communiti case octob june | D000086382 | T047;T067 |
36,243,678 | transcriptom clusterin sb transfect neuron cell elucid protect mechan hypoxia oxid stress hood seal cystophora cristata brain hood seal cystophora cristata exhibit impress dive skill toler extend durat asphyxia hypoxia oxid stress without suffer irrevers neuron damag thus expos hypoxia vitro neuron fresh cortic hippocamp tissu hood seal maintain membran potenti time longer neuron mice aim identifi molecular mechan under intrins neuron hypoxia toler previous compar transcriptom visual cortex reveal sb clusterin apolipoprotein j two stress protein involv neurolog disord character hypox condit remark high express hood seal compar ferret overexpress murin neuron cell hn sb clusterin neuroprotect effect cell expos hypoxia howev specif role hypoxia remain larg unknown | D018696;D046048 | T121;T169;T015 |
36,243,665 | posit statement spanish societi paediatr infecti diseas introduct implement assess antimicrobi stewardship programm paediatr hospit past year antimicrobi resist increas becom serious public health problem irrat use antimicrobi one main contributor antimicrobi resist paediatr popul free problem antimicrobi wide prescrib age group often inappropri introduct antimicrobi stewardship programm asp proven crucial curb emerg antimicrobi resist intern level need develop specif paediatr asp recognis account differ adult paediatr patient concern infect approach diagnosi treatment reason paediatr asp multidisciplinari programm led paediatr infecti diseas specialist use specif paediatr indic day treatment antimicrobi suscept pattern paediatr popul clinic indic help identifi area improv develop effect target intervent hand support leadership pertin scientif societi also essenti purpos document present posit sociedad espaola de infectologa peditrica seip spanish societi paediatr infecti diseas concern implement paediatr asp hospit spain provid tool facilit applic hospit throughout region health care system countri | D000073602;D003141;D000890 | T121;T047;T058 |
36,243,656 | prognost valu percist petct metabol paramet neoadjuv treatment patient esophag cancer assess clinic util percist criteria chang f fdg petct quantit paramet prognost factor progress free surviv cancer specif surviv css patient esophag cancer treat chemoradiotherapi | D000072078;D004938 | T191;T060 |
36,243,621 | human neutrophil kinet call revisit old evid half life human neutrophil still controversi estim rang h day debat settl understand neutrophil product bone marrow bm potenti limit emerg neutropoiesi follow infect trauma furthermor cellular lifespan great influenc potenti effect neutrophil adapt immun respons posit blood neutrophil exchang differ tissu particular bm contain largest pool matur neutrophil furthermor propos oldest neutrophil first die follow call conveyor belt model guid principl shed new light interpret exist neutrophil lifespan data offer recommend futur research | D009504;D001854 | T025 |
36,243,620 | microbiota deriv antigen drive cd intraepitheli lymphocyt cdiel develop cd intraepitheli lymphocyt cdiel tissu resid cell cytotox regulatori properti togeth peripher regulatori cell control intestin inflamm recent bousbain colleagu identifi microbiota deriv conserv antigen induc cdiel differenti promot regulatori function attenu sever murin coliti | D000075942;D064307 | T001;T025;T032;T028 |
36,243,592 | transcutan immun via dissolv microneedl protect mice lethal influenza hn virus challeng avian influenza hn virus first emerg sinc spread china five season wave human influenza hn virus infect associ high fatal rate thus effect vaccin virus need present studi evalu use dissolv microneedl mns load influenza hn vaccin term dissolut time insert capac insert depth structur integr hn virus vitro vitro result show mns dissolv within min depth skin penetr coat matrix materi solut hn protein agglomer detect hn deliveri time humor immun respons vivo mous model antigen retent time longer mns intramuscular im inject humor respons show similar im administr mn administr increas level function systemat antibodi protect live influenza aanhui virus ahhn protect level determin analysi patholog section infect lung mn im administr yield result superior control group taken togeth find demonstr use dissolv mns deliv influenza hn vaccin promis immun approach | D064766;D007251;D007252;D009976 | T047;T121;T109;T129;T005 |
36,243,591 | trend hpv vaccin administr hpv vaccin coverag children raceethn socioeconom status covid pandem integr health care system california sought evalu trend hpv vaccin whether impact covid pandem hpv vaccin vari raceethn neighborhood depriv index ndi | D053918;D030361;D000086382;D019033 | T047;T093;T116;T058;T121;T129;T067 |
36,243,590 | phase ii singl center random doubl blind parallel control clinic studi evalu immunogen safeti two dose schedul serogroup acyw meningococc polysaccharid conjug vaccin singl center random doubl blind parallel control studi evalu immunogen safeti two dose schedul serogroup acyw meningococc polysaccharid conjug vaccin tetanus toxoid tt conjug protein infant toddler month old | D022401;D008589 | T121;T047;T109;T129 |
36,243,589 | catch immunis migrant children melbourn qualit studi provid determin key challeng current model immunis servic deliveri australia meet need migrant children experi higher burden vaccin prevent diseas lower immunis rate compar non migrant children understand experi immunis provid critic design effect tailor intervent improv servic studi aim identifi facilit barrier provid deliv comprehens catch immunis servic migrant children melbourn australia | D006297;D014171 | T098;T080;T033 |
36,243,538 | electr conduct conic nanopor symmetr asymmetr salt mixtur studi experiment electr conduct voltag curv negat posit charg conic nanopor bath ionic solut monoval dival trival cation electrochem biolog relev ionic concentr better understand interact pore surfac charg mobil ion singl salt salt mixtur consid paid attent effect conduct cation valenc pore charg asymmetri pore charg invers phenomena due trival ion singl salt salt mixtur addit describ small concentr multival ion tune nanopor conduct due monoval major ion togeth effect charg addit ionic conduct fluorid induc negat differenti conduct phenomena compil discuss previous present experiment data offer signific insight interact fix mobil charg confin nanoscal volum use establish check new model describ ionic transport vicin charg surfac | D058608 | T082 |
36,243,535 | review natur inspir gate membran concept design applic natur constant sourc inspir technolog develop recent studi natur inspir materi expand micro nanoscal facilit new breakthrough design materi uniqu properti various type superhydrophob surfac inspir lotusric leaf exampl natur inspir surfac special wettabl properti new class function surfac whose design inspir pitcher plant slipperi liquid infus porous surfac slip review summar properti design criteria fabric strategi work mechan surfac specif focus slip applic slip field membran technolog slipperi liquid infus membran slim also review membran also known liquid gate membran due gate function capillari stabil liquid membran pore lead smart gate mechan similar gate ion channel biolog system pore open close respons ambient stimuli eg pressur temperatur ion differ type stimuli respons smart gate membran introduc properti applic review detail final challeng perspect slip smart gate membran discuss review provid thorough discuss practic applic natur inspir function surfac membran pave way futur research develop emerg field | D007473 | T123;T116 |
36,243,529 | random batch ewald method charg particl isotherm isobar ensembl develop accur high effici scalabl random batch ewald rbe method conduct molecular dynam simul isotherm isobar ensembl npt ensembl charg particl period box discret langevin equat motion deriv use suitabl lagrangian rbe method build mini batch strategi fourier space ewald summat pressur forc comput cost reduc n per time step implement method larg scale atomicmolecular massiv parallel simul packag report accur simul result dynam quantiti statist equilibrium typic system includ atom bulk water semi isotrop membran system numer simul massiv supercomput cluster also perform show promis central process unit effici rbe | D056004 | T044;T066 |
36,243,527 | probe intra inter molecular interact rotat spectroscopi case odor aminoacetophenon water neon complex chirp puls fourier transform microwav spectrum aminoacetophenon aromat chemic speci odor properti record ghz frequenc rang analyz obtain precis inform structur monom neon water complex conform monom determin format reson assist hydrogen bond rahb carbonyl amino group lead format bicycl like aromat structur accord cycl form non coval bond prefer phenyl ring interact site neon complex water lie molecular plane form strong hydrogen bond carbonyl group coupl ancillari interact methyl group leav intramolecular rahb unchang experiment find support atom molecul symmetri adapt perturb theori allow determin hydrogen bond intermolecular interact energi respect | D011789;D014867 | T121;T170;T197 |
36,243,526 | vibrat level general mors potenti general mors potenti gmp extens mors potenti mp addit exponenti term addit paramet compens mp erron behavior long rang part interact potenti addit term paramet vibrat level gmp solv analyt unlik case mp present sever numer approach solv vibrat problem gmp base galerkin method name laguerr polynomi method lpm symmetr lpm polynomi expans method pem appli vibrat level homonuclear diatom molecul b f high level theoret near full configur interact ci electron ground state potenti energi surfac experiment measur vibrat level report overal lpm produc vibrat state gmp converg within spectroscop accuraci cm order magnitud faster much fewer basi functionsgrid point colbert miller discret variabl represent cn dvr method three homonuclear diatom molecul examin studi python librari fit solv gmp similar potenti download https gitlabcomgdsuwgener mors solver | D000465;D014732 | T170;T070 |
36,243,522 | predict uncertainti valid comput chemist valid predict uncertainti pu becom essenti task modern comput chemistri design quantifi reliabl predict meteorolog calibr sharp cs framework wide use optim valid uncertainti awar machin learn ml method howev applic limit ml serv principl framework pu valid present articl intend step step introduct concept techniqu pu valid cs framework adapt specif comput chemistri present method rang elementari graphic check sophist one base local calibr statist concept tight introduc method illustr synthet dataset appli uncertainti quantif data issu comput chemistri literatur | D035501 | T033 |
36,243,515 | postop mri ankl foot mani surgic procedur oper use treat ankl foot disord radiographi first line imag postop surveil evalu pain dysfunct comput tomographi scan mr imag use evalu mr imag accur test soft tissu assess mr imag protocol adjust includ basic advanc metal artifact reduct chose surgic approach select common type procedur discuss normal abnorm postop mr imag appear highlight potenti complic articl review common use surgic techniqu normal abnorm mr imag appear | D016512;D005534 | T047;T037 |
36,243,514 | postop mr imag knee meniscus surgeri treat torn meniscus common orthoped procedur radiologist frequent ask imag patient new recurr knee pain meniscus surgeri howev surgeri alter mr imag appear meniscus make diagnosi recurr tear diagnost challeng articl review relev anatomi meniscus surgic techniqu use treat meniscus tear role convent mr imag mr arthrographi assess postop meniscus key mr imag find distinguish intact postop meniscus recurr tear | D007718;D000072600;D000070600 | T023;T037 |
36,243,513 | postop magnet reson imag knee ligament articl describ postop appear reconstruct ligament knee focus anterior cruciat ligament acl expect evolv signal alter graft time also review postop appear ligament reconstruct patient multiligament knee injuri mlki isol pcl tear also discuss | D000070598;D007718;D016119 | T023;T037 |
36,243,512 | postop mr imag pubic symphysi athlet pubalgia mr imag evalu valuabl patient prior surgeri athlet pubalgia present new recurr persist groin pain clinic intervent histori well comparison preoper imag essenti imag interpret imag awar expect unexpect postop find mr imag find concern infect new injuri contralater injuri concomit sourc symptom hip patholog report present | D001265;D011631;D013177 | T056;T030;T037 |
36,243,511 | postop hip mr imag postop imag hip use domin radiograph comput tomographi occasion nuclear medicin studi given surgeri arthroplasti less common core decompress indic procedur perform expand well beyond arthroplasti includ labral procedur resect repair reconstruct osteochondroplasti acetabuloplasti remov loos bodi among other result postop evalu hip often includ mr imag mr arthrographi articl discuss normal postop appear common complic associ hip arthroscopi hip arthroplasti focus mr imag | D000077;D008279 | T059;T023;T060;T170 |
36,243,510 | postop imag wrist hand articl overview general specif complic occur common wrist hand surgeri knowledg differ surgic techniqu essenti postop imag evalu general complic includ infect complex region pain syndrom problem relat surgic approach open arthroscop bone heal problem frequent fractur wrist specif complic distal radius fractur scaphoid fractur associ tendon ruptur secondari friction nonunion secondari malign briefli review differ approach triangular fibrocartilag injuri includ acut degen lesion scapholun instabl common instabl import indic surgeri pin fixat acut set arthroplasti arthrodesi chronic irrepar injuri one common surgeri wrist carpal tunnel releas although complic uncommon radiologist familiar normal appear patholog chang surgeri trapeziometacarp joint osteoarthr frequent especi postmenopaus women sever treatment option depend stage | D021361;D014954 | T023;T037 |
36,243,509 | postop mr imag elbow elbow injuri grow problem particular among overhead athlet children adolesc particip sport activ goal surgic manag elbow injuri restor capsuloligament osseous contribut stabil howev postop mr imag evalu difficult varieti surgic techniqu avail lack postop mr imag suspect complic mani diagnos clinic revis may perform without imag articl review common perform surgic techniqu select elbow injuri postop mr imag find complic | D001265;D004551 | T030;T037 |
36,243,508 | postop mr imag rotat cuff mr imag crucial evalu symptomat patient undergon rotat cuff surgeri familiar anatom rotat cuff repair surgic option irrepar cuff tear expect normal postop find potenti complic essenti better mr imag interpret | D017006;D000070636 | T023;T037;T047;T033 |
36,243,507 | postop mri shoulder instabl follow anterior shoulder instabl surgeri patient may present new recurr symptom postop imag includ mr imag may obtain patient assess integr repair tissu orthoped fixat hardwar graft familiar differ oper techniqu expect normal appear complic help appropri interpret imag studi articl provid overview current treatment guidelin surgeri option patient anterior shoulder instabl review normal abnorm postop imag appear shoulder joint treatment common surgic stabil techniqu | D007593;D012783;D012785 | T047;T023;T030;T037;T033 |
36,243,506 | postop mr imag joint technic consider postop mr imag joint common request yet artifact caus metal orthoped implant remain signific challeng imag interpret effect artifact reduct essenti identifi postsurg complic prosthesi loosen infect advers local tissu reaction periarticular soft tissu injuri articl review basic advanc metal artifact reduct mr imag techniqu appli various clinic protocol success postop mr imag small larg joint | D008279;D008670 | T059;T060;T170;T197 |
36,243,503 | contrast enhanc intraop ultrasound liver contrast enhanc intraop ultrasound ce ious relat new valuabl tool increas use adjunct comput tomographi mri ious patient undergo liver surgeri ce ious import role main set discrimin indetermin lesion detect cirrhot liver convent ious detect colorect liver metastasi may overlook imag modal intraop natur imag interpret allow ce ious direct affect surgic decis make may import affect patient outcom | D015179;D008113 | T191 |
36,243,502 | current futur applic fluoresc guid surgeri head neck cancer despit improv medic manag head neck cancer posit surgic margin rate remain relat unchang past year emphas need improv intraop imag tumor visual review provid detail summari preoper anatom imag techniqu nonspecif fluoresc imag modal recent emerg tumor target fluorophor intraop imag futur fluoresc guid surgeri head neck cancer | D006258;D025321 | T191;T061 |
36,243,501 | intraop molecular imag lung cancer review intraop molecular imag show great promis surgic treatment lung cancer particular tumor local margin assess identif addit nodul even potenti lymph node assess advanc imag agent fluoresc surgic camera key although imag agent current food drug administr approv target near infrar agent otl phase iii trial | D008175 | T191 |
36,243,500 | applic three dimension print surgic oncolog varieti three dimension print techniqu materi facilit creation custom model promis improv surgic procedur patient outcom three dimension print model allow patient traine experienc surgeon explor anatomi direct visual tactil feedback although print model serv rang purpos includ preoper plan educ skill refin patient specif intraprocedur guid implant much work remain decreas turnaround time cost print model collect long term effect data refin regulatori oversight print medicin | D008953;D000071077 | T091;T170;T073 |
36,243,499 | molecular anatom imag neuroendocrin tumor positron emiss tomographi pet somatostatin receptor sstr ligand taken lead imag neuroendocrin tumor net articl review role sstr pet scan manag net includ indic scan pitfal interpret imag select criteria peptid receptor radionuclid therapi also discuss complementari role fluorodeoxyglucos pet particular patient high grade diseas | D018358 | T191 |
36,243,498 | innov parathyroid local imag cervic surgeri local identif parathyroid gland key remov abnorm hyperfunct gland preserv normal gland challeng natur parathyroid local foster innov imag techniqu local gland cervic oper advanc preoper imag includ pet base imag modal pair comput tomographi mri anatom correl surgeri parathyroid autofluoresc contrast enhanc fluoresc techniqu use adjunct intraop identif | D049950;D010280 | T047;T023 |
36,243,497 | indocyanin green use esophagectomi esophagectomi mani factor influenc anastomosi surgic factor includ anastomot tension locat anastomosi surgic techniqu perfus conduit use fluoresc angiographi possibl avenu object evalu gastric conduit lot variabl way tool use result indic articl discuss various method fluoresc angiographi determin intestin perfus use indocyanin green fluoresc imag data associ clinic outcom | D004938;D016629 | T191;T061 |
36,243,496 | advanc imag aid segmentectomi lung cancer pulmonari segmentectomi becom wide accept techniqu resect earli stage lung cancer intraop identif small nodul within lung parenchyma definit segment anatomi essenti oncolog segment resect signific enhanc recent advanc imag techniqu advanc imag nodul local use preoper marker three dimension comput tomographi delin segment anatomi sentinel lymph node map becom import compon plan perform minim invas anatom segmentectomi particular well suit evolv robot assist platform | D008175;D011013 | T191;T061 |
36,243,495 | aminolevulin acid imag malign glioma high grade glioma common malign primari brain tumor adult glioma infiltr render difficult treat like recur increas extent resect associ improv progress free surviv overal surviv sever month introduct aminolevulin acid ala fluoresc guid surgeri allow surgeon better differenti neoplast tissu normal tissu thus achiev greater extent resect develop new intraop imag modal combin ala may provid addit benefit glioma patient | D001932;D005910;D025321 | T191;T061 |
36,243,494 | molecular imag estrogen receptor posit breast cancer clinic applic whole bodi dedic breast positron emiss tomographi f fluoroestradiol f fes food drug administr approv radiopharmaceut use molecular imag estrogen receptor er combin pet f fes may improv diagnosi er posit breast cancer metastat set provid insight tumor heterogen articl review data use f fes imag treatment select stage imag lobular breast cancer novel breast specif imag tool dedic breast pet | D001943;D011960 | T191;T116;T192 |
36,243,491 | stent thrombosi percutan coronari intervent bare metal last generat drug elut stent sinc introduct clinic practic differ type coronari stent develop becom avail treatment coronari arteri diseas stent thrombosi st uncommon harm complic percutan coronari implant high occurr acut myocardi infarct risk mortal among sever procedur clinic predictor type coronari stent strong determin st articl review avail evid use coronari stent type modern era relat risk st | D054855;D062645;D013927 | T046;T061;T074 |
36,243,490 | patient select protect percutan coronari intervent benefit evolut percutan coronari intervent pci enabl complet revascular complex coronari lesion howev simultan patient present nowaday higher rate comorbid may lead lower physiolog toler complex pci avoid hemodynam instabl pci achiev safe complet revascular protect pci use mechan circulatori support devic develop howev patient would benefit protect pci still debat henc review provid practic approach select patient outlin current clinic data assess util protect pci high risk patient | D006353;D062645 | T061;T074 |
36,243,489 | manag coronari complic coronari complic increas rare remain fatal manag prompt effect review incid manag prevent serious coronari complic includ acut vessel closur dissect reflow thrombosi air embol well mechan complic includ perfor stent dislodg atherectomi burr entrap | D017225 | T061 |
36,243,488 | stent restenosi stent restenosi isr remain potenti complic percutan coronari intervent even era drug elut stent treatment remain suboptim neoatherosclerosi import compon patholog isr acceler drug elut stent compar bare metal stent coronari angiographi gold standard evalu morpholog isr although comput tomographi angiographi emerg altern noninvas modal evalu presenc isr drug coat balloon stent reimplant current mainstay treatment isr choic treatment base clinic background lesion morpholog | D023903;D054855;D062645 | T061;T047;T074 |
36,243,487 | recent advanc antiplatelet therapi complex percutan coronari intervent antithrombot therapi cornerston secondari cardiovascular prevent percutan coronari intervent pci improv drug elut stent des design materi last decad prompt develop new antithrombot strategi current guidelin recommend tailor dual antiplatelet therapi dapt accord clinic present individu ischem bleed risk given grow number complex pci procedur perform nowaday prioriti defin optim antithrombot treatment challeng patient subset review articl sought summar discuss current evid antiplatelet therapi patient undergo complex pci | D054855;D062645 | T061;T074 |
36,243,486 | coronari bifurc lesion percutan coronari intervent pci drug elut stent des treatment coronari bifurc lesion cbls still technic demand main higher rate acut chronic complic compar non cbls although provision stent ps consid prefer strategi cbls systemat two stent techniqu doubl kiss dk crush consid patient complex left main lm cbls non lm cbls stratifi definit criteria intracoronari imag andor physiolog evalu use optim cbls intervent pci des treatment cbls technic demand main higher rate acut chronic complic compar non cbls ps default strategi cbls doubl kiss dk crush associ better clinic outcom compar ps patient complex lm cbls non lm cbls stratifi definit criteria intracoronari imag andor physiolog evalu use tool guid treatment cbls use drug coat balloon cbls need data support clinic benefit | D015906;D003324;D023921;D054855;D062645 | T061;T047;T074 |
36,243,485 | intravascular lithotripsi treatment calcifi coronari arteri diseas intravascular lithotripsi ivl use acoust shock wave balloon base deliveri system modifi sever calcifi atherosclerot coronari vascular lesion prepar stent implant ivl result circumferenti longitudin calcium fractur improv transmur vessel complianc facilit subsequ stent expans without requir high pressur balloon dilat clinic trial demonstr ivl safe low rate major advers cardiac event hospit year low rate sever angiograph complic effect high rate procedur success easi use littl learn curv appli treatment sever calcifi coronari arteri | D015906;D003324;D008096;D061205 | T061;T047 |
36,243,484 | saphen vein graft intervent even though saphen vein graft svgs common use surgic conduit long term patenc limit acceler atherosclerosi often result acut coronari syndrom asymptomat occlus svg intervent associ signific challeng signific risk distal embol result periprocedur myocardi infarct short term restenosi long term sever individu trial compar bare metal stent drug elut stent svg intervent review articl discuss pathophysiolog svg lesion indic svg intervent challeng encount also technic consider svg intervent support evid | D015906;D054855 | T061;T074 |
36,243,483 | calcium modif percutan coronari intervent moder sever calcif increas procedur complic impair long term prognosi post pci intravascular imag particular optic coher tomographi oct use guid treatment calcifi lesion weight sum calcium length arc thick oct predict adequ stent expans identifi atherectomi requir intravascular imag guidanc various techniqu alon combin may use algorithm fashion modifi calcifi lesion calcium fractur balloon angioplasti cuttingscor balloon intravascular lithotripsi ivl atherectomi devic excim laser improv stent expans intravascular imag essenti treatment stent restenosi lumin andor ablumin peri strut calcium present | D017225;D062645;D061205 | T061;T047 |
36,243,482 | left main diseas tradit treatment left main coronari arteri diseas recommend coronari arteri bypass graft superior long term outcom compar medic treatment plain old balloon angioplasti howev improv percutan coronari intervent techniqu introduct drug elut stent led chang treatment strategi left main coronari arteri diseas cumul data revascular base clinic evid | D003324;D054855 | T047;T074 |
36,243,479 | emerg technolog wound manag field technolog advanc incorpor wound care manag enhanc prevent specialti mattress pressur map assess use modern imag treatment dress activ therapi review specif equip evid base practic context manag pressur injuri patient spinal cord injuri | D003668;D013119 | T047;T037 |
36,243,478 | current concept surgic manag lymphedema decis offer surgic intervent lymphedema requir collabor input involv specialist address patient expect invas procedur diseas sever consensus constitut success failur complex decongest therapi pursu surgic intervent surgeri potenti fundament affect pathophysiolog diseas state power tool use correct dogma surgeri offer given clinic situat undergo revis area ongo research | D008198;D008209 | T023;T046;T047 |
36,243,477 | introduct burn burn injuri often devast leav victim suffer lifelong sequela optim care burn care begin time injuri start burn shock extend discharg intervent scar care advanc mobil mani dress use treat burn wound although dress replac surgic excis earli excis wound closur autograft gold standard burn care burn wound often result scar caus contractur pain disfigur member physic medicin rehab pm r team integr improv qualiti life burn patient follow recoveri articl function provid brief overview burn care nonburn special audienc discuss select advanc burn intervent provid introduct role pm r life burn patient | D002056;D011788 | T078;T037 |
36,243,476 | post amput skin wound care manag post amput wound skin individu evolv process although consensus recommend avail optim wound heal occur dress provid appropri level moistur manag edema assist contractur prevent limb protect manag comorbid condit complic might imped heal well nutrit optim help promot wound closur faster time heal increas opportun likelihood prosthet fit use work toward improv function independ | D001186 | T074 |
36,243,475 | shoe brace consider insens foot shoe consider diabet foot diabet individu peripher neuropathi risk develop foot ulcer due musculoskelet abnorm abnorm load gait cycl lead elev plantar pressur prevent diabet foot ulcer practition regular screen patient presenc neuropathi well neuroarthropathi prescrib appropri shoe orthot base best avail clinic evid although wide avail potenti data driven custom orthot shoe wear base plantar pressur data prevent develop diabet foot ulcer effect ultim prevent lower limb amput | D003920;D017719;D003929 | T047 |
36,243,474 | stepwis approach nonop oper manag diabet foot ulcer multipl factor lead develop diabet foot ulcer dfu ultim goal treat dfu prevent amput initi therapi includ debrid maintain healthi wound environ offload set infect nonheal dfu surgic intervent may necessari goal articl discuss key aspect initi examin standard nonop treatment oper treatment option patient dfu | D003920;D017719 | T047 |
36,243,473 | role hyperbar oxygen therapi treatment wound hyperbar oxygen hbo medicar approv treatment varieti diagnos includ chronic nonheal wound radiat necrosi hyperbar oxygen therapi hbot use high pressur satur hemoglobin dissolv oxygen blood plasma creat hyperoxem environ nourish revers local tissu injuri caus ischemia hypoxemia hbot expens without risk therefor under etiolog present diagnosi must adequ treat start hbo adjunct therapi get maximum benefit | D006931;D011832 | T061;T047;T037 |
36,243,472 | nutrit wound care nutrit import compon health well compromis nutrit status link increas risk wound develop difficulti manag decreas wound heal rate malnutrit contribut immunocompromis system reduc collagen synthesi diminish tensil strength wound heal process assess optim nutrit status incorpor part comprehens treatment plan individu wound nutrit care plan must includ individu intervent design address individu nutrit diagnosi articl review role nutrit wound prevent manag treatment | D044342;D044623 | T061;T047;T058 |
36,243,471 | establish comprehens wound care team program comprehens interdisciplinari wound care team great import manag acut chronic recurr wound manag function best patient member team regular discuss regard wound care plan provid effici timeli patient center care articl review role differ disciplin manag wound disciplin includ rehabilit physician wound care nurs regist nurs certifi nurs assist surgic team specialist infecti diseas mental health dietician patient caregiv case studi also provid | D018802;D010820 | T058;T097 |
36,243,470 | seat wheel mobil clinician contribut wound care team mani know wound care team consist physician nurs special train mani may know physic therapist pt occup therapist ot train seat wheel mobil address skin injuri peopl full time wheelchair user ptsot address fit use wheelchair bodi look daili function look caus skin injuri otherwis seen help prevent futur therefor make pts ot expertis valuabl part wound care team | D014910 | T074 |
36,243,469 | comprehens manag pressur injuri review pressur injuri pis spectrum local tissu destruct develop often boni promin pis result combin extrins eg pressur shear friction moistur intrins nutrit status spastic decreas sensat vascular diseas factor given complex etiolog manag pis requir multidisciplinari approach team health care profession address extrins intrins factor local wound care general recommend stage pis surgic intervent stage | D003668 | T047 |
36,243,468 | consider skin wound care pediatr patient wound care pediatr special area practic requir consider factor uniqu pediatr patient slowli grow bodi evid support treatment choic vulner popul critic wound expert develop overse evid base skin care regimen wound treatment practic articl discuss common issu pediatr skin wound care success prevent treatment plan collabor address development physiolog social need pediatr patient famili conflict plan care limit resourc frequent challeng | D010372;D017592;D014945 | T061;T091;T040 |
36,243,467 | general skin issu adult rehabilit popul skin abil function optim compromis skin integr alter goal skin manag rehabilit includ maintain skin integr avoid skin injuri provid earli intervent comprehens educ long term skin manag assess whole patient well skin essenti common issu seen rehabilit age skin incontin dermat intertrigoyeast surgic wound pressur injuri address | D005242;D017592;D014549;D003872 | T046;T061;T047;T184 |
36,243,464 | liver disord associ metabol imbal dairi cow articl discuss complex interrelationship origin metabol stress trigger unbal result suboptim liver health sever chang occur around parturit requir drastic increment lipolyt activ lead signific adipos tissu remodel increas activ ultim exceed liver normal function inabl liver perform proper metabol regul togeth concurr inflammatori state alter immun status physiolog imbal result greater risk diseas lower milk product fertil compromis well lifespan herd | D002418;D008107 | T047;T033 |
36,243,463 | toxicolog insult bovin liver liver subject toxic insult due role metabol exogen substanc direct filtrat blood portal circul carri absorb toxin gastrointestin system metabol xenobiot liver facilit high concentr cytochrom p enzym catalyz biotransform foreign substanc conjug toxin metabolit increas solubl enhanc excret understand common hepatotoxin circumst lead exposur cattl aid clinician recogn clinic syndrom submit appropri diagnost sampl confirm suspect diagnos | D003577;D015262 | T131;T126;T116;T123 |
36,243,462 | roughag dietari influenc liver abscess mani research evalu differ nonantibiot dietari intervent reduc liver abscess includ degre grain process roughag particl size ionophor inclus level supplement prebiot probiot howev altern inconsist outcom proven success new technolog methodolog allow descript character microbiom within cattl environ liver abscess may help elucid etiolog liver abscess format allow target intervent provid solut replac reduc antimicrobi use current use reduct liver abscess preval | D004043;D008100 | T047;T168 |
36,243,461 | non antimicrobi method control liver abscess beef feedlot non microbi approach avail decreas incid liver abscess decreas degre grain process might use method decreas dietari starch eg feed digest fiber sourc distil grain limit effect manag feed intak decreas daili variat littl effect abscess feed addit essenti oil tannin live yeast yeast ferment product provid benefit research need lack reproduc vitro vivo model rapid screen potenti non antimicrobi method limit progress | D000821;D002418;D008100 | T047;T168 |
36,243,460 | antimicrobi biolog method control liver abscess antimicrobi product approv control liver abscess vari amount data compar negat control tylosin data support reduct total risk ratio sever risk ratio liver abscess due reduct use antimicrobi vaccin control liver abscess preval intrigu howev avail vaccin appear effect control preval liver abscess especi diseas preval high | D002418;D008100 | T047 |
36,243,459 | microbi ecolog liver abscess cattl emerg evid regard microbiom liver abscess las gastrointestin tract cattl suggest reexamin etiopathogenesi las warrant microbiom studi use rrna gene sequenc demonstr las high polymicrobi hundr bacteri taxa typic found lesion slaughter fusobacteria bacteroidet equal domin phyla within las follow proteobacteria gut liver axi ie bidirect crosstalk gut liver link varieti liver diseas human investig host microbiom interact cattl may lead improv method prevent | D002418;D008100;D064307 | T001;T047;T032;T028 |
36,243,458 | effect liver abscess carcass outcom year liver abscess document reduc beef system valu infect liver tissu result poorer growth perform evidenc diminish live carcass weight leaner lesser muscl carcass greater rate trim negat outcom compound reduc anim carcass valu technolog advanc method reduc prevent liver abscess goal scientist produc worldwid | D002418;D008100 | T047 |
36,243,457 | liver abnorm cattl effect liver abscess growth product cattl liver abscess identifi multipl class cattl cattl consum higher energi diet may greater preval abscess presenc sever liver abscess associ reduc dri matter intak daili gain gain effici individu fed anim preval abscess within pen anim increas growth perform worsen import liver metabol damag due abscess could negat affect energi util preliminari analysi indic sever liver abscess incid increas requir metaboliz energi mainten | D002418;D008100 | T047 |
36,243,456 | pathogenesi liver abscess cattl liver abscess bacteri infect occur entri via portal vein pyogen bacteria hepat parenchyma liver abscess polymicrobi infect howev fusobacterium necrophorum rumin bacterium primari etiolog agent rumin acidosi disrupt protect barrier function rumin epithelium facilit entri colon f necrophorum rumin wall subsequ entri portal circul virul factor f necrophorum contribut evas host defens mechan caus tissu damag set infect liver potenti role hindgut pathogenesi remain investig | D002418;D005674;D008100 | T047 |
36,243,453 | gain function research term gain function gof describ gain new function organ genet chang natur occur experiment genet modif gain function research virus enhanc transmiss virus replic virul host rang immun evas drug vaccin resist get insight viral mechan creat analyz anim model acceler drug vaccin develop improv pandem prepared subset gof research concern gofroc enhanc potenti pandem pathogen eppp could harm human relat issu militari use research dual use research concern durc influenza coronavirus main research target caus pandem airborn infect two studi avian influenza virus initi global debat temporari gof paus unit state end new regulatori framework european union china gof durc main cover legisl laboratori safeti genet modifi organ coronavirus outbreak gof research made signific advanc includ analys modifi mer like sar like virus creation synthet sar cov virus platform generat mutat gof research virus still play import role futur need clarifi differ overlap gof research gofroc durc need special oversight author still debat | D000086382;D007251 | T047;T067 |
36,243,452 | antifung activ lactic acid bacteria applic food biopreserv lactic acid bacteria lab ubiquit bacteria associ spontan lactic ferment veget dairi meat product general recogn safe gras involv transform probiot lacto ferment food high desir nutraceut properti antifung activ one excit properti lab possibl applic food bio preserv altern chemic preserv mani recent research work develop antifung activ lab demonstr capac produc various antifung compound ie organ acid pla proteinac compound peptid cyclic dipeptid fatti acid compound differ properti hydrophil hydrophob amphiphil effect lab control spoilag pathogen fungi demonstr differ agricultur food product due synergist effect antifung compound differ properti amphiphil compound allow contact target microbi cell hydrophil compart antifung hydrophob compound studi interact compound three properti de develop order highlight mechan action make lab profit improv shelf life nutraceut properti food | D056546 | T007 |
36,243,451 | microbi communiti halit deposit hypersalin environ larg region earth surfac underlain salt deposit evapor ancient ocean popul extrem halophil microb microbiolog ancient evaporit well studi ecolog halit deposit recent form nacl salticl stalactit structur speleothem triassic halit mine less well character microbiom kilroot salt mine profil use convent enhanc cultur techniqu halophil archaeal isol six known genera halophil halotoler bacteri isol genera obtain cultur independ metagenom approach also reveal cultur techniqu inadvert bias toward specif taxa need optim isol procedur requir enhanc cultiv divers speleothem form satur brine uniqu structur potenti entomb haloarchaea cell thousand year within fluid inclus presenc fluid inclus alongsid high abund gene relat glycerol metabol biofilm format persist cell format high suggest environment nich could promot longev surviv final previous studi report discoveri novel biocatalyst kilroot mine microbiom suggest environ may untap sourc chemic divers high biodiscoveri potenti | D064307;D012965 | T028;T121;T001;T196;T197;T130;T032 |
36,243,448 | imag manifest pulmonari melioidosi case seri melioidosi endem diseas southeast asia oceania caus gram negat bacillus burkholderia pseudomallei studi adult patient colombia microbiolog diagnos pulmonari melioidosi review chest x ray chest comput tomographi ct studi patient met criteria acut infect met criteria chronic infect common find chest x ray consolid nodul cavit ct studi consolid nodul observ case area consolid predomin locat basal central zone area cavit observ pleural effus mediastin lymph node patient acut pulmonari melioidosi n find observ nodul mix pattern nodul consolid pleural effus mediastin lymph node two patient chronic pulmonari melioidosi cavit acut lung infect b pseudomallei radiolog manifest similar pneumonia due caus area diseas endem essenti includ acut melioidosi differenti diagnosi pulmonari nodul chronic melioidosi differenti diagnosi cavit chronic lung lesion | D016957;D008171;D008554;D010996;D011014;D014396 | T007;T050;T047 |
36,243,447 | neuroinvas diseas due west nile virus clinic imag find associ emerg pathogen west nile virus wnv arbovirus infect human be caus sever neuroinvas diseas take outbreak occur spain refer articl review clinic imag find neuroinvas diseas due wnv collect demograph clinic laboratori imag ct mri variabl patient wnv infect diagnos center main clinic find fever headach alter level conscious neuroimag studi especi mri use diagnosi follow patient common imag find foci increas signal intens thalamus brainstem weight sequenc illustr find case hospit | D014901;D014902 | T047;T005 |
36,243,446 | urgent unexpect find oncolog hematolog patient practic approach imag urgent unexpect find common oncolog haematolog patient articl review import point includ european societi radiolog guidelin propos practic approach report communic find effici approach explain illustr exampl radiologist provid ad valu manag find help refer clinician reach best decis end essenti know imag manifest common find must report urgent specif toxic differ treatment complic tumour cathet infect thrombosi moreov crucial consid individu patient treatment risk factor clinic situat immun status | D006405;D008495 | T091 |
36,243,445 | chest calcif beyond lung parenchyma review thorac calcif frequent found chest radiograph cts occur wide varieti disord although calcif harmless sequela previous diseas provid import inform establish diagnosi articl review differ type calcifi lesion found chest focus lesion outsid lung parenchyma locat base approach differenti diagnosi use provid reader diagnost pearl discuss clinic import differ type calcif | D002114;D008168 | T047;T046;T023 |
36,243,444 | dual energi ct technic consider clinic applic although dual energi ct initi describ hounsfield remain underus clinic practic therefor import emphas clinic benefit limit techniqu iodin map make possibl quantifi uptak iodin import character tumor lung perfus pulmonari nodul tumor respons new treatment dual energi ct also make possibl obtain virtual singl energi imag virtual imag without iodin contrast without calcium well separ materi uric acid fat elabor hepat iron overload map articl review clinic benefit technic limit improv understand dual energi ct expand use clinic practic | D007455;D014057 | T121;T060;T123;T196 |
36,243,443 | onlin train radiolog covid pandem covid pandem chang method use teach radiolog medic school resid program continu medic educ need continu train radiolog situat requir physic distanc led massiv use onlin method internet provid solut mitig problem paper aim present seri use freeli access resourc share foamrad philosophi onlin train radiolog covid pandem | D000086382;D020375;D007396;D011871 | T047;T065;T091;T097;T067 |
36,243,442 | brain ct request emerg depart realiti evalu common reason request brain ct studi emerg depart calcul preval urgent acut patholog popul group | D003287;D004636 | T093;T073;T130 |
36,243,441 | brain mri without anesthesia children less month old use general anesthesia infant involv short term long term risk aim studi evalu efficaci brain mri without anesthesia infant younger month old immobil pillow | D016477;D008279 | T059;T068;T060;T170 |
36,243,440 | vascular loop cerebellopontin angl clinic radiolog correl brainstem situat posterior fossa connect brain spinal cord owe locat nerv brainstem close relat vascular structur | D002530;D014012 | T047;T184;T030;T037 |
36,243,439 | signal intens dentat nucleus administr macrocycl gadolinium base contrast agent gadoter meglumin observ studi contradictori result report hyperintens globus pallidus andor dentat nucleus unenhanc weight magnet reson mr imag exposur various gadolinium base contrast agent chang signal intens vari differ gadolinium base contrast agent aim determin whether signal intens dentat nucleus increas unenhanc weight imag patient undergon multipl studi macrocycl gadolinium base contrast agent gadoter meglumin thorough review literatur corrobor result | D003287;D005682 | T196;T130 |
36,243,436 | intervent treatment vascular anomali vascular anomali high variabl angioarchitectur locat flow dynam individu multidisciplinari approach treatment requir focus improv patient qualiti life appropri percutan endovascular treatment patient satisfact follow intervent therapi general high acknowledg complet cure may alway possibl | D011788;D054079 | T078;T190 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.